This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Aronovich A, Nur Y, Shezen E, Rosen C, Zlotnikov Klionsky Y, Milman I, et al. A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure. Blood. 2013;122:2562–71.
Borkowska S, Suszynska M, Mierzejewska K, Ismail A, Budkowska M, Salata D, et al. Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs). Leukemia. 2014;28:2148–54.
Gur-Cohen S, Itkin T, Chakrabarty S, Graf C, Kollet O, Ludin A, et al. PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells. Nat Med. 2015;21:1307–17.
Nevo N, Zuckerman T, Gur-Cohen S, Kollet O, Avemaria F, Shpall EJ, et al. PAR1 expression predicts clinical G-CSF CD34(+) HSPC mobilization and repopulation potential in transplanted patients. Hemasphere. 2019;3:e288.
Nguyen TS, Lapidot T, Ruf W. Extravascular coagulation in hematopoietic stem and progenitor cell regulation. Blood. 2018;132:123–31.
Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003;9:1370–6.
Zhang Y, Wittner M, Bouamar H, Jarrier P, Vainchenker W, Louache F. Identification of CXCR4 as a new nitric oxide-regulated gene in human CD34+ cells. Stem Cells. 2007;25:211–9.
Xu D, Yang M, Capitano M, Guo B, Liu S, Wan J, et al. Pharmacological activation of nitric oxide signaling promotes human hematopoietic stem cell homing and engraftment. Leukemia. 2020;35:229–34.
Adamiak M, Abdelbaset-Ismail A, Moore JBT, Zhao J, Abdel-Latif A, Wysoczynski M, et al. Inducible nitric oxide synthase (iNOS) is a novel negative regulator of hematopoietic stem/progenitor cell trafficking. Stem Cell Rev Rep. 2017;13:92–103.
Stettner N, Rosen C, Bernshtein B, Gur-Cohen S, Frug J, Silberman A, et al. Induction of nitric-oxide metabolism in enterocytes alleviates colitis and inflammation-associated colon cancer. Cell Rep. 2018;23:1962–76.
Fares I, Chagraoui J, Lehnertz B, MacRae T, Mayotte N, Tomellini E, et al. EPCR expression marks UM171-expanded CD34(+) cord blood stem cells. Blood. 2017;129:3344–51.
Denham JW, Hauer-Jensen M. The radiotherapeutic injury-a complex ‘wound’. Radiother Oncol. 2002;63:129–45.
Hendrikx PJ, Martens CM, Hagenbeek A, Keij JF, Visser JW. Homing of fluorescently labeled murine hematopoietic stem cells. Exp Hematol. 1996;24:129–40.
Steidl U, Kronenwett R, Rohr UP, Fenk R, Kliszewski S, Maercker C, et al. Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells. Blood. 2002;99:2037–44.
LeBlanc R, Roy J, Demers C, Vu L, Cantin G. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant. 1999;23:991–6.
Acknowledgements
This work was partially supported by the Israel Science Foundation (ISF), a joint grant from the Israel Science Foundation (ISF) and the National Natural Science Foundation of China (NSFC), Minerva Foundation and the Federal German Ministry for Education and Research, Steven B. Rubenstein Research Fund, Weizmann Stem Cell Institute, The WIS Moross Integrated Cancer Center, Asher Pertman and Wayne Pertman, and the Estate of David Levinson.
Author information
Authors and Affiliations
Contributions
NN and OK reviewed literature, designed and conducted experiments, analyzed results, and wrote the paper. SGC, LAOM, FA, MB, EKM, MH, PC, and SB designed and performed experiments, analyzed data, and reviewed the manuscript. WR participated in designing experiments and reviewed the manuscript. TL reviewed literature, designed the study concept, guided the research, and wrote the paper.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Nevo, N., Ordonez-Moreno, LA., Gur-Cohen, S. et al. Enhanced thrombin/PAR1 activity promotes G-CSF- and AMD3100-induced mobilization of hematopoietic stem and progenitor cells via NO upregulation. Leukemia 35, 3334–3338 (2021). https://doi.org/10.1038/s41375-021-01194-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-021-01194-5